Enhancing diversity in clinical trial populations: An agency-industry perspective
Feature ArticlesMathilda Fienkeng, PharmD, MS, RAC • Alysha Croker, PhD • Zaida Recinos-Vasquez, MS, MS • Monique Carter, MS, RAC, FRAPS
Clinical TrialsGlobalPharmaceuticals